Bruker Makes Routine Magnetic Resonance Spectroscopy More Broadly Accessible for Chemical Analysis Outside Central LabsBusiness Wire • 03/26/21
Bruker (BRKR) Down 0.2% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/18/21
Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D GenomicsBusiness Wire • 03/18/21
GlycoPath Inc. Secures Seed Investment to Further Develop, Validate and Commercialize GlycoTyper™ Mass Spectrometry-Based Assays for Liver Fibrosis, Cirrhosis and Liver Cancer (HCC)PRNewsWire • 03/10/21
Bruker Announces New Results in Deep, Unbiased Plasma Proteomics, PaSER 1.1 Software and New Cross-linking Consumables at US HUPO 2021Business Wire • 03/08/21
New Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurements and Deep Learning for 4D ProteomicsBusiness Wire • 02/25/21
Bruker Corporation (BRKR) CEO Frank Laukien on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/16/21
Bruker Announces Date and Time of Fourth Quarter 2020 Earnings Release and WebcastBusiness Wire • 02/02/21
numares and Bruker Sign Agreement to Enable Advanced Metabolomics-based Clinical DiagnosticsBusiness Wire • 01/21/21
Bruker Corporation to Present at the 39th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/06/21
Bruker and Evosep Announce Major Progress in Unbiased, Quantitative True Single-cell ProteomicsBusiness Wire • 01/05/21
Bruker Introduces MBT Sepsityper® Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood CulturesBusiness Wire • 01/04/21
Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD MarkBusiness Wire • 12/18/20